TrialLiver international : official journal of the International Association for the Study of the Liver2026

Naltrexone Is Superior to Placebo for Abstinence and Craving Reduction in Alcohol-Associated Cirrhosis: NAL-CI Trial.

Manasa Alla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.